Adaptimmune Therapeutics plc ( ADAPY) - Stock Earnings
ADAPY Upcoming earnings
Estimated EPS and revenue columns are available to paid members.
| Date | EPS (actual / est.) | Revenue low (est.) | Revenue (actual / est.) | Revenue high (est.) |
|---|---|---|---|---|
| Aug. 24, 2026, midnight | — / — | — | — / — | — |
ADAPY Quarterly earnings
| Date | Earnings | Revenue |
|---|---|---|
| 2024Q4 | -74.2 million USD | 3.2 million USD |
| 2025Q1 | -47.6 million USD | 7.3 million USD |
| 2025Q2 | -30.3 million USD | 13.7 million USD |
ADAPY Yearly earnings
Analyst consensus estimates are available to paid members.
| Date | Earnings | Revenue |
|---|---|---|
| 2022 | -165.5 million USD | 27.1 million USD |
| 2023 | -113.9 million USD | 60.3 million USD |
| 2024 | -70.8 million USD | 178.0 million USD |
| 2026 Est. | — | — |
ADAPY
Price: $0.03
52 week price:
Earnings Per Share: -0.66 USD
Exchange: PNK
Sector: Healthcare
Industry: Biotechnology
Market Capitalization: 7.2 million